key: cord-0295587-5v64ketw
authors: Sugrue, J. A.; Smith, M.; Posseme, C.; Charbit, B.; Milieu Interieur Consortium,; Bourke, N. M.; Duffy, D.; O'Farrelly, C.
title: Rhesus negative males have an enhanced IFNγ-mediated immune response to influenza A virus
date: 2021-10-07
journal: nan
DOI: 10.1101/2021.10.07.21264642
sha: f2bdc53ca24c172dfeb7624babca2fc1568b8fd5
doc_id: 295587
cord_uid: 5v64ketw

The Rhesus D antigen (RhD) has been associated with susceptibility to several viral infections. Reports suggest that RhD-negative individuals are better protected against infectious diseases and have overall better health. However, potential mechanisms contributing to these associations have not yet been defined. Here, we used transcriptomic and genomic data from the Milieu Interieur cohort of 1000 healthy individuals to explore the effect of RhD on immune responses. We used the rs590787 SNP in the RHD gene to classify the 1000 donors as either RhD-positive or -negative. Whole blood was stimulated with LPS, polyIC, and the live influenza A virus and the NanoString human immunology panel of 560 genes used to assess donor immune response and to investigate sex specific effects. Using regression analysis, we observed no significant differences in responses to polyIC or LPS between RhD-positive and -negative individuals. However, upon sex-specific analysis, we observed over 30 differentially expressed genes (DEGs) between RhD-positive (n=401) and RhD-negative males (n=78). Interestingly these Rhesus-associated differences were not seen in females. Further investigation, using gene set enrichment analysis, revealed enhanced IFN{gamma} signalling in RhD-negative males. This amplified IFN{gamma} signalling axis may explain the increased viral resistance previously described in RhD-negative individuals.

as either RhD-positive or -negative. Whole blood was stimulated with LPS, polyIC, and the live 23 influenza A virus and the NanoString human immunology panel of 560 genes used to assess 24 donor immune response and to investigate sex specific effects. Using regression analysis, we 25 observed no significant differences in responses to polyIC or LPS between RhD-positive and -26 negative individuals. However, upon sex-specific analysis, we observed over 30 differentially 27 expressed genes (DEGs) between RhD-positive (n=401) and RhD-negative males (n=78). 28

Interestingly these Rhesus-associated differences were not seen in females. Further 29 investigation, using gene set enrichment analysis, revealed enhanced IFNg signalling in RhD-30 . CC-BY-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted October 7, 2021. ; https://doi.org/10.1101/2021.10.07.21264642 doi: medRxiv preprint

The Rhesus D blood group antigen (RhD) system is an important clinical factor in transfusion 35 and obstetric medicine. RhD status is determined based on the presence or absence of the 36 rhesus antigen, a transmembrane protein found on the surface of red blood cells (Avent and 37 Reid, 2000) . The function of the RhD antigen is largely unknown, although it may play a role 38 in maintaining erythrocyte membrane integrity or transport of ammonium and carbon 39 dioxide (Marini et al., 2000; Westhoff, 2004; Endeward et al., 2008) . The rhesus protein is 40 highly immunogenic and resulting antibodies can induce severe adverse reactions in RhD-41 negative individuals should they encounter the D antigen following an unmatched blood 42 transfusion. RhD-negative women can also be sensitised during pregnancy with an RhD-43 positive foetus or during delivery, often leading to haemolytic disease of the new born in 44 subsequent pregnancies with RhD-positive foetuses (Pegoraro et al., 2020) . Several studies have demonstrated that RhD-positive and -negative subjects differ in 50 resistance to the pathological effects of aging, fatigue, and smoking (Flegr, Hoffmann and 51

Dammann, 2015). RhD-negative individuals also appear to be protected against infection, 52

including latent toxoplasmosis (Flegr, Hoffmann and Dammann, 2015). RhD status also 53 appears to affect susceptibility to SARS-CoV-2; in a study of 14,112 donors, RhD-negative 54 individuals had a lower risk of initial infection, intubation and death-suggesting a protective 55 role for RhD negativity (Zietz, Zucker and Tatonetti, 2020) . RhD negativity varies substantially 56 across different populations and may potentially confer an as yet unknown fitness advantage 57 (Perry et al., 2012) . A major challenge in determining potential effects of RhD status on anti-58 viral immunity is the lack of large, relevant human cohort studies with the power to detect 59 potentially subtle immune differences. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted October 7, 2021. ; https://doi.org/10.1101/2021.10.07.21264642 doi: medRxiv preprint

The Milieu Interieur (MI) study is comprised of a cohort of 1000 healthy individuals, stratified 62 by age (20-69, n=200 per decade) and sex (500 males and 500 females). The overall aim of 63 the MI study is greater understanding of the determinants of variation in the immune 64 responsiveness of healthy adult humans (Thomas et al., 2015) . Previous work from MI and 65 others has shown that sex and CMV serostatus are key drivers of variation in the human 66 immune response (Patin et al., 2018; Picarda and Benedict, 2018) . Substantial genomic and 67 transcriptomic data has been generated on the cohort to date and analysed using agnostic 68 approaches (Patin et al., 2018 , Piasecka et al., 2018 . We were particularly interested to compare RhD-positive and -negative males and females, 79 as sex is emerging as a key factor in determining outcomes to viral infection, especially SARS-80

CoV-2 and influenza (Klein et al., 2020) . is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted October 7, 2021. 

The presence or absence of rs590787, a SNP in the RhD gene, was used to determine the RhD 102 status of donors in our cohort ( Fig.1 ) (Shi and Luo, 2019) . There was no difference in the 103 distribution of RhD-positive or -negative individuals between males and females in our cohort 104 (Fig. 2a) . 83% of donors in the MI cohort were RhD-positive (Fig. 2b) . The genotype 105 frequencies of the Rhesus SNP rs590787 were compared to those from the 1000 genomes 106 cohort (Auton et al., 2015). The genotype frequencies in the MI cohort were similar to those 107 observed for Europeans in the 1000 Genome Study (Fig. 2c) . 108 . CC-BY-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted October 7, 2021. ; https://doi.org/10.1101/2021.10.07.21264642 doi: medRxiv preprint Whole blood was incubated for 22 hours and expression of 560 immune genes quantified. 120

Gene expression in the unstimulated condition was similar between all RhD-positive and -121 negative individuals. Given the important sex-specific differences emerging regarding 122 pathogen susceptibility, we also investigated sex-specific effects. The cohort was also 123 stratified by sex and assessed for differential gene expression between RhD-positive and -124 negative males and females. Baseline immune gene expression was similar between RhD-125 positive and -negative males and females (Fig. 3(i) ). 126 127 . CC-BY-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Lee, 2013). Using linear regression, we found the response to both polyIC and LPS to be similar 133 in RhD-negative and -positive individuals whether male or female (Fig. 3(ii) , (iii)). Data is 134

presented as a heatmap with 100 randomly selected genes shown. Differences in cell counts 135

can have a major impact on the whole blood transcriptional response (Piasecka, et al., 2018) . 136 Therefore, we compared major circulating immune populations between RhD-positive and -137 negative individuals. Following FDR correction, we observed no significant differences in any is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted October 7, 2021. comparing the entire cohort, or when looking at females only (Fig. 4a) . Interestingly, however, 157 when examining the whole blood response to influenza A virus between RhD-positive and -158 negative males only, we observed differential expression of 35 immune related genes (Fig.  159   4b, Fig. 4c ; q <0.1, regression analysis with FDR correction). To further interrogate differences 160 in the immune response to influenza A between RhD-positive and -negative individuals we 161 used gene set enrichment analysis (GSEA). Using this approach we found the IFNg pathway to 162 be significantly enriched in RhD-negative males (Fig. 4d) . is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted October 7, 2021. RhD status had never been carried out. RhD-negative individuals have reduced risk of initial 177 infection with SARS-CoV-2, as well as decreased risk of both intubation and death (Zietz, 178 Zucker and Tatonetti, 2020). The increased IFNg signalling that we find in RhD-negative donors 179 could contribute to reduced susceptibility to SARS-CoV-2 infection and pathology. suggests that analysis focused exclusively on specific TLR ligands may not be sufficient to 191 identify differential effects of blood groups on the innate immune response to infectious 192 agents. Studies using whole organisms may be more informative. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted October 7, 2021. ; https://doi.org/10.1101/2021.10.07.21264642 doi: medRxiv preprint

The distribution of blood groups, including RhD, varies globally-this may explain, at least in 205 part, the regional differences in disease occurrence. RhD-negativity is particularly enriched in 206

East Asian populations (28% RhD-negative) compared with European or African populations 207 (16% and 6%, respectively) (Dahlén et al., 2021) . This may reflect the different historic disease 208 burdens on these populations. As the cohort used in our study includes only donors of 209

Western European descent, more cohorts should be analysed to include individuals of 210 difference ethnicities to further probe the differences in the immune response between RhD-211 positive and -negative individuals. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted October 7, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted October 7, 2021. ; https://doi.org/10.1101/2021.10.07.21264642 doi: medRxiv preprint All participants were genotyped for the rs590787 SNP, through a genome-wide SNP array, 266

using HumanOmniExpress and HumanExomeBeadChips (Patin et al., 2018) . Rhesus status 267 

Total RNA was extracted from the TruCulture cell pellets for the 1000 Milieu Interieur donors 280 using NucleoSpin 96 miRNA kit (Macherey-Nagel). RNA concentrations were measured using 281

Quantifluor RNA system kit (Promega) and RNA integrity numbers were determined using the 282 Agilent RNA 6000 Nano kit (Agilent Technologies). The expression levels of 560 immune 283 related genes were quantified before and after stimulation using NanoString hybridization 284 arrays, producing highly reproducible transcriptomic data. Gene expression data were 285 normalized as previously described ( 

Transcriptomic data was analysed using R Studio (https://www.rstudio.com/.) In order to 290 account for potential sex differences the cohort was subdivided into males and females. 291

Linear regression including CMV serostatus as a covariate was used to assess differences 292 between RhD-positive and -negative individuals. p-values were adjusted for false discovery 293 using the FDR correction to generate a q-value. A q-value of q<0.1 was taken as significant. 294

Scatterplots were created using GraphPad Prism. Volcano plots were created in R studio using 295 the EnhancedVolcano package. Heatmaps were generated in R using the package pheatmap. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted October 7, 2021. ; https://doi.org/10.1101/2021.10.07.21264642 doi: medRxiv preprint

Pathway analysis was carried out on genes with q-values (<0.1), using Gene Set Enrichment 299

Analysis, found at https://www.gsea-msigdb.org/gsea/index.jsp. The genes were compared 300 to panels of genes using the Hallmarks gene set. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted October 7, 2021. ; https://doi.org/10.1101/2021.10.07.21264642 doi: medRxiv preprint . CC-BY-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted October 7, 2021. ; https://doi.org/10.1101/2021.10.07.21264642 doi: medRxiv preprint

Biological sex impacts COVID-19 outcomes', PLOS Pathogens

Mechanisms of sex disparities in 386 influenza pathogenesis

The human Rhesus-associated RhAG protein and a kidney 389 homologue promote ammonium transport in yeast

Polyinosinic Acid Is a Ligand for Toll-like Receptor 3 *', 392

Recognition of lipopolysaccharide pattern by TLR4 395 complexes

Genome-wide detection of allelic gene 398 expression in hepatocellular carcinoma cells using a human exome SNP chip

Natural variation in the parameters of innate immune cells is 401 preferentially driven by genetic factors

Hemolytic disease of the fetus and newborn due to Rh(D) 404 incompatibility: A preventable disease that still produces significant morbidity and mortality 405 in children

Evolutionary genetics of the human Rh blood group system

Distinctive roles of age, sex, and genetics 411 in shaping transcriptional variation of human immune responses to microbial challenges

Cytomegalovirus: Shape-Shifting the Immune System

Interferon-γ Inhibits Ebola Virus Infection', PLOS Pathogens

Underreporting of Hepatitis B and C virus infections -Pennsylvania

Functional Exhaustion of Type I and II Interferons Production in 423

Severe COVID-19 Patients ', Frontiers in Medicine

Effects of RHD gene polymorphisms on distinguishing weak D or 426

DEL from RhD− in blood donation in a Chinese population

Sex differences in immune responses that underlie COVID-19 429 disease outcomes

The Milieu Intérieur study -An integrative approach for study of 431 human immunological variance

Functions of natural killer cells

The Rh blood group system in review: a new face for the next 436 decade

Associations between blood type and COVID-439 19 infection, intubation, and death

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted October 7, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted October 7, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted October 7, 2021. ; https://doi.org/10.1101/2021.10.07.21264642 doi: medRxiv preprint